Why did GAAP EPS rise 32% while adjusted EPS rose only 9%?

GAAP diluted EPS of $2.86 includes an $802 million pre-tax gain (about $1.26 per share) from terminating the Resideo indemnification and reimbursement agreement. Adjusted EPS excludes this gain, along with other items such as the $0.60 divestiture-related costs, a $0.25 environmental liability adjustment, and a $0.17 asbestos settlement loss. The adjusted figure of $2.82 is the better measure of underlying operating performance.

Did Honeywell change its full-year guidance?

Yes. The company raised its full-year organic sales growth outlook to about 6% and its adjusted EPS guidance to $10.60-$10.70, up $0.10 at the midpoint from the prior range. These figures include the expected $0.21 EPS impact of the Solstice spin-off. Sales guidance was lowered to $40.7-$40.9B from $40.8-$41.3B, reflecting roughly $0.7B of spin-related reduction. Free cash flow guidance was reduced to $5.2-$5.6B, mainly due to the spin.

What is the status of Honeywell's planned separations?

The Solstice Advanced Materials spin-off is set for October 30, 2025. The separation of Automation and Aerospace Technologies is on track for completion in the second half of 2026. Automation will be reorganized into three new segments (Building Automation, Process Automation and Technology, and Industrial Automation) beginning in Q1 2026, and Aerospace Technologies will remain a reporting segment through the separation.

Why did free cash flow decline in the quarter?

Q3 free cash flow fell 16% to $1.45B from $1.72B. The main driver was the $1.59B cash payment to terminate the Resideo indemnification agreement. Operating cash flow rose 65% to $3.29B, partly on the Resideo termination inflow, but the payment is excluded from the company's adjusted free cash flow definition. Investors should still note that this cash outflow is real and affects reported FCF.

What are the main risks highlighted for investors?

Key concerns include weak Industrial Automation performance (flat process solutions, declining productivity solutions and Europe exposure), margin pressure from cost inflation, and UOP sales declining 13% due to licensing delays. Higher environmental and asbestos-related charges, execution risk in multiple separations and divestitures, and macroeconomic and trade risks (tariffs, supply chain, geopolitics) also warrant attention. Strategic review outcomes for Productivity Solutions and Warehouse and Workflow Solutions remain uncertain.

HON 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed October 23, 2025. Cited figures are marked; the original filing is the authoritative source.

Honeywell reported third-quarter 2025 results that met or exceeded guidance: sales of $10.4 billion^a (up 7% reported, 6% organic), GAAP EPS of $2.86 (up 32%), and adjusted EPS of $2.82 (up 9%).

Orders rose 22%, and backlog reached a new record, led by Aerospace Technologies and Energy and Sustainability Solutions. Operating margin contracted 220 bps to 16.9%, while segment margin fell 50 bps to 23.1%. The GAAP EPS increase was largely driven by a $802 million^b pre-tax gain from the termination of the Resideo indemnification agreement, which investors should weigh against the underlying adjusted figures.

Adjusted EPS was also burdened by a $161 million^c environmental liability increase and a $112 million asbestos divestiture settlement loss, both excluded from adjusted EPS. Management raised full-year 2025 organic sales growth to approximately 6% and raised adjusted EPS guidance to $10.60-$10.70 (up $0.10 at the midpoint). These figures now include the expected $0.21 dilution from the October 30, 2025 spin-off of Solstice Advanced Materials.

Full-year sales guidance is $40.7^d-$40.9 billion, and free cash flow guidance is $5.2-$5.6 billion, reduced by about $0.2 billion from the spin. Excluding the Bombardier agreement impact, adjusted EPS is expected to grow about 3% year over year. Honeywell is executing a three-way separation: Solstice is being spun off, Automation and Aerospace are to be separated in the second half of 2026, and automation will be reorganized into three new segments starting in Q1 2026.

Free cash flow in the quarter fell 16% to $1.5 billion, mainly because of the $1.59 billion Resideo termination payment. Investors should watch execution of the separations, the quality of organic growth in Industrial Automation (which was weak), and the impact of the strategic reviews of Productivity Solutions and Warehouse and Workflow Solutions.

02—Key points

Key Highlights

Q3 2025 sales of $10.4B, up 7% reported and 6% organic; orders up 22%; total backlog hit a record high.
GAAP EPS of $2.86 (up 32%) was inflated by an $802M pre-tax Resideo indemnification termination gain; adjusted EPS of $2.82 (up 9%) beat the high end of guidance.
Aerospace Technologies organic sales rose 12%, with commercial aftermarket up 19% and defense and space up 10%, though segment margin fell 160 bps to 26.1%.
Industrial Automation was weak: organic growth of 1%, segment profit down 16%, and margin down 150 bps to 18.8%, with productivity solutions declining 3%.
Full-year 2025 guidance raised: organic growth about 6%, adjusted EPS $10.60-$10.70 (up $0.10 at midpoint) after including a $0.21 spin-off dilution; sales $40.7-$40.9B.
Free cash flow fell 16% to $1.45B in Q3 due to the $1.59B Resideo termination payment; full-year FCF guidance is $5.2-$5.6B.
Portfolio transformation continues: Solstice Advanced Materials spin on October 30, 2025; Automation/Aerospace separation targeted for 2H 2026; Bendix asbestos liabilities divested in October.

03—Questions

Frequently Asked Questions

Why did GAAP EPS rise 32% while adjusted EPS rose only 9%?
GAAP diluted EPS of $2.86 includes an $802 million pre-tax gain (about $1.26 per share) from terminating the Resideo indemnification and reimbursement agreement. Adjusted EPS excludes this gain, along with other items such as the $0.60 divestiture-related costs, a $0.25 environmental liability adjustment, and a $0.17 asbestos settlement loss. The adjusted figure of $2.82 is the better measure of underlying operating performance.
Did Honeywell change its full-year guidance?
Yes. The company raised its full-year organic sales growth outlook to about 6% and its adjusted EPS guidance to $10.60-$10.70, up $0.10 at the midpoint from the prior range. These figures include the expected $0.21 EPS impact of the Solstice spin-off. Sales guidance was lowered to $40.7-$40.9B from $40.8-$41.3B, reflecting roughly $0.7B of spin-related reduction. Free cash flow guidance was reduced to $5.2-$5.6B, mainly due to the spin.
What is the status of Honeywell's planned separations?
The Solstice Advanced Materials spin-off is set for October 30, 2025. The separation of Automation and Aerospace Technologies is on track for completion in the second half of 2026. Automation will be reorganized into three new segments (Building Automation, Process Automation and Technology, and Industrial Automation) beginning in Q1 2026, and Aerospace Technologies will remain a reporting segment through the separation.
Why did free cash flow decline in the quarter?
Q3 free cash flow fell 16% to $1.45B from $1.72B. The main driver was the $1.59B cash payment to terminate the Resideo indemnification agreement. Operating cash flow rose 65% to $3.29B, partly on the Resideo termination inflow, but the payment is excluded from the company's adjusted free cash flow definition. Investors should still note that this cash outflow is real and affects reported FCF.
What are the main risks highlighted for investors?
Key concerns include weak Industrial Automation performance (flat process solutions, declining productivity solutions and Europe exposure), margin pressure from cost inflation, and UOP sales declining 13% due to licensing delays. Higher environmental and asbestos-related charges, execution risk in multiple separations and divestitures, and macroeconomic and trade risks (tariffs, supply chain, geopolitics) also warrant attention. Strategic review outcomes for Productivity Solutions and Warehouse and Workflow Solutions remain uncertain.

04—Continue

← View all 8-K filings